| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
achaete-scute family bHLH transcription factor 1 | 0.552 | 0.692 | 0.68 |
|
group | 0.220 | None | 1.000 | 1 | 0 | 2006 | 2017 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
group | 0.270 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
aggrecan | 0.528 | 0.846 | 1.00 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
angiopoietin 1 | 0.446 | 0.808 | 0.95 |
|
group | 0.290 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
angiopoietin 2 | 0.410 | 0.846 | 0.83 |
|
group | 0.250 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.600 | None | 0.844 | 1 | 0 | 1994 | 2020 | ||||||||
|
angiotensin II receptor type 2 | 0.496 | 0.808 | 8.2E-03 |
|
group | 0.250 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
apolipoprotein D | 0.584 | 0.577 | 5.4E-04 |
|
group | 0.220 | None | 1.000 | 1 | 0 | 2008 | 2014 | ||||||||
|
arachidonate 5-lipoxygenase activating protein | 0.612 | 0.731 | 7.1E-02 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
bone morphogenetic protein 4 | 0.422 | 0.808 | 0.96 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.300 | None | 0.917 | 1 | 0 | 2003 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 1 | 0.449 | 0.923 | 0.12 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
calpastatin | 0.541 | 0.846 | 4.1E-12 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
caspase 2 | 0.565 | 0.731 | 1.5E-03 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
group | 0.300 | None | 0.933 | 1 | 0 | 2005 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
chondroitin sulfate proteoglycan 4 | 0.599 | 0.615 | 2.6E-05 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
complement factor H | 0.441 | 0.885 | 0.86 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
endothelin receptor type A | 0.426 | 0.885 | 0.99 |
|
group | 0.510 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
epoxide hydrolase 2 | 0.568 | 0.654 | 1.8E-21 |
|
group | 0.220 | None | 1.000 | 1 | 0 | 2007 | 2008 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
group | 0.230 | None | 1.000 | 1 | 0 | 2012 | 2020 | ||||||||
|
GDNF family receptor alpha 1 | 0.619 | 0.615 | 0.12 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2001 | 2018 |